Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Fuller

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Diabetologia|April 1, 1974
Intralipid triglyceride and oral glucose toleranceT Gibson, J H Fuller, S L Grainger, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2001
Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibitionN Chaturvedi, J H Fuller, F Pokras, et al.
Kidney International|June 26, 2001
Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic thresholdN Chaturvedi, S Bandinelli, R Mangili, et al.
Diabetologia|May 1, 1995
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications StudyJ M Stephenson, J H Fuller, G C Viberti, et al.
Diabetologia|October 6, 2001
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in DiabetesN J Morrish, S L Wang, L K Stevens, et al.
Diabetologia|August 1, 1991
Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in DiabeticsN J Morrish, L K Stevens, J H Fuller, et al.
Diabetologia|August 1, 1991
Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in DiabeticsN J Morrish, L K Stevens, J H Fuller, et al.
Diabetes Care|May 26, 2001
The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general populationH M Colhoun, D P Francis, M B Rubens, et al.
Diabetologia|February 5, 2005
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications StudyM T Schram, N Chaturvedi, C G Schalkwijk, et al.
Diabetes Care|March 31, 1999
Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study GroupM Toeller, A E Buyken, G Heitkamp, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Diabetologia|April 1, 1974
Intralipid triglyceride and oral glucose toleranceT Gibson, J H Fuller, S L Grainger, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2001
Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibitionN Chaturvedi, J H Fuller, F Pokras, et al.
Kidney International|June 26, 2001
Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic thresholdN Chaturvedi, S Bandinelli, R Mangili, et al.
Diabetologia|May 1, 1995
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications StudyJ M Stephenson, J H Fuller, G C Viberti, et al.
Diabetologia|October 6, 2001
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in DiabetesN J Morrish, S L Wang, L K Stevens, et al.
Diabetologia|August 1, 1991
Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in DiabeticsN J Morrish, L K Stevens, J H Fuller, et al.
Diabetologia|August 1, 1991
Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in DiabeticsN J Morrish, L K Stevens, J H Fuller, et al.
Diabetes Care|May 26, 2001
The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general populationH M Colhoun, D P Francis, M B Rubens, et al.
Diabetologia|February 5, 2005
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications StudyM T Schram, N Chaturvedi, C G Schalkwijk, et al.
Diabetes Care|March 31, 1999
Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study GroupM Toeller, A E Buyken, G Heitkamp, et al.
Pageof 17